iBio (IBIO) Stock Will Not Undergo A Reverse Split

iBio IBIO Stock News

iBio Inc (NYSEAMERICAN: IBIO) has been a hot topic as of late. After announcing a collaboration with CC Pharming to develop a vaccine for the Wuhan coronavirus, the stock started to soar. However, before the run, the company was in trouble. A detrimentally low trading price was threatening delisting and harming the company’s ability to … Read more

iBio, Inc. (IBIO) Stock: Headed For The Top On New Commercial Relationship

iBio, Inc. (NYSEAMERICAN: IBIO) is flying early on in the trading session this morning, and for good reason. The company announced the commencement of a strategic commercial relationship that’s clearly a point of exitement for investors. Today, we’ll talk about: The new relationship; what we’re seeing from IBIO as a result; and what we’ll be … Read more

iBio Inc (IBIO) Stock: Gaining Big On Expanded Capabilities

iBio Inc (NYSEAMERICAN: IBIO) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company announced the expansion of its capabilities and services. Of course, this news led to excitement among investors, sending the stock screaming for the top. Today, we’ll talk about the news, what we’re seeing from … Read more

Ibio (IBIO) Stock: Gaining On Intellectual Property Update

Ibio Inc (NYSEMKT: IBIO) is having an overwhelmingly strong day in the market today, and for good reason. The company provided an intellectual property update early this morning that’s causing excitement among investors who are pushing the stock toward the top. As is nearly always the case, our partners at Trade Ideas were the first … Read more

In The Market Today: iBio (IBIO), Atossa Genetics (ATOS), Gilead Sciences (GILD), Twitter (TWTR)

iBio Finds Gains On Positive Data iBio INC (NYSEMKT: IBIO) iBio is having a great day in the market today after announcing that Dr. Feghali-Bostwick made a new discovery that proves to be an extension of the doctor’s previous discovery. Dr. Feghali-Bostwick previously found that a peptide derived from endostatin can prevent or ameliorate fibrosis … Read more

iBio (IBIO) Climbs On Publication Of Positive Candidate Data

iBio Inc (NYSEMKT: IBIO) iBio is having a great day in the market today after announcing new discoveries found by iBio’s scientific collaborator, Carol Feghali-Bostwick, Ph.D. Today, we’ll take a look at the new discoveries found, how the market reacted to the news, and what we can expect to see from the stock moving forward. … Read more

Today In Biotech: AVEO Pharmaceuticals (AVEO) | Synergy Pharmaceuticals (SGYP) | iBio (IBIO) | EnteroMedics (ETRM) | EnteroMedics (ETRM)

AVEO Pharmaceuticals Stock Climbs On Licensing Agreement AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) AVEO announced today that it has entered into an exclusive, worldwide license agreement with Novartis for it’s first-in-class, potent, humanized inhibitory antibody targeting growth differentiation factor 15. The antibody is known as AV-380 and the agreement also includes related antibodies as well as … Read more

iBio Stock Continues Bullish Path

iBio Inc (NYSEMKT: IBIO) Last week proved to be an incredible week for iBio after the company announced that it had received a notice from the US patent office letting them know that their patent had been approved. Today, we’ll talk about the patent that created all the hype, what we’re seeing in the market … Read more